Literature DB >> 11508659

Prognostic factors in hepatic metastases of colorectal carcinoma: immunohistochemical analysis of tumor biological factors.

A Nanashima1, H Yamaguchi, T Sawai, E Yamaguchi, H Kidogawa, S Matsuo, T Yasutake, T Tsuji, M Jibiki, T Nakagoe, H Ayabe.   

Abstract

The present study was designed to provide a systemic analysis of prognosis in 62 patients who underwent hepatic resection for colorectal liver metastasis. The analyzed factors included microvessel counts stained by CD34 and expression of two adhesion molecules, E-cadherin and CD44 variant exon 6-(v6) in these tumors. No significant factors related to recurrence were identified and only negative expression of CD44v6 tended to correlate with recurrence (P = 0.075). A short disease-free period to recurrence was noted in patients with high CEA levels (>10 ng/ml) and H2/3 classification. A short surgical margin, H2/3 classification, high microvessel counts (>60/field, x200), and negative expression of CD44v6 and E-cadherin tended to be associated with poor prognosis. A high microvessel count was the most significant prognostic factor by multivariate Cox proportional hazards regression model. Hepatic resection without tumor exposure and a careful follow-up in cases identified with poor prognostic factors are necessary.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508659     DOI: 10.1023/a:1010680815954

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis.

Authors:  N Gunji; T Oda; T Todoroki; N Kanazawa; T Kawamoto; K Yuzawa; A Scarpa; K Fukao
Journal:  Cancer       Date:  1998-05-01       Impact factor: 6.860

2.  Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection.

Authors:  A Nanashima; H Yamaguchi; T Sawai; T Yasutake; T Tsuji; M Jibiki; E Yamaguchi; T Nakagoe; H Ayabe
Journal:  J Gastroenterol Hepatol       Date:  1999-10       Impact factor: 4.029

3.  Benefits and safety of hepatic resection for colorectal metastases.

Authors:  K E Harmon; J A Ryan; T R Biehl; F T Lee
Journal:  Am J Surg       Date:  1999-05       Impact factor: 2.565

4.  Surgical experience with hepatic colorectal metastasis.

Authors:  A L Bradley; W C Chapman; J K Wright; J W Marsh; S Geevarghese; K T Blair; C W Pinson
Journal:  Am Surg       Date:  1999-06       Impact factor: 0.688

5.  The expression of MMP-2 and TIMP-2 in patients with primary colorectal adenocarcinoma: correlation with liver metastasis.

Authors:  M Mukai; S Sadahiro; N Tokunaga; K Ishizu; I Ito; T Kameya; K Ishikawa; H Iwase; T Suzuki; H Ishida; T Tajima; H Makuuchi
Journal:  Oncol Rep       Date:  1999 Sep-Oct       Impact factor: 3.906

6.  A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer.

Authors:  K Yasui; T Hirai; T Kato; A Torii; K Uesaka; T Morimoto; Y Kodera; Y Yamamura; T Kito; N Hamajima
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

7.  Gain of chromosome 20 is a frequent aberration in liver metastasis of colorectal cancers.

Authors:  A Nanashima; H Yamaguchi; T Yasutake; T Sawai; H Kusano; Y Tagawa; T Nakagoe; H Ayabe
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

8.  Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators?

Authors:  J Y Wang; J M Chiang; L B Jeng; C R Changchien; J S Chen; K C Hsu
Journal:  Dis Colon Rectum       Date:  1996-08       Impact factor: 4.585

9.  Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.

Authors:  S Nakamori; M Kameyama; S Imaoka; H Furukawa; O Ishikawa; Y Sasaki; T Kabuto; T Iwanaga; Y Matsushita; T Irimura
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

10.  Functional correlation between cell adhesive properties and some cell surface proteins.

Authors:  M Takeichi
Journal:  J Cell Biol       Date:  1977-11       Impact factor: 10.539

View more
  10 in total

1.  Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy.

Authors:  Seok Reyol Choi; Jin Seok Jang; Jong Hun Lee; Myung Hwan Roh; Min Chan Kim; Won Sup Lee; Waqar Qureshi
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

Review 2.  A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.

Authors:  A S Khazali; A M Clark; A Wells
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

3.  Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis.

Authors:  Jin C Kim; Seon A Roh; Hee C Kim; Kum H Koo; Young K Cho; Chang S Yu; Young M Kwon; Jung S Kim
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

4.  Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer.

Authors:  Francisco J Vizoso; José C Fernández; María D Corte; Miguel Bongera; Richard Gava; María T Allende; José L García-Muñiz; Manuel García-Morán
Journal:  J Cancer Res Clin Oncol       Date:  2004-08-06       Impact factor: 4.553

5.  CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.

Authors:  Lili Wang; Qin Liu; Dongliang Lin; Maode Lai
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

6.  Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.

Authors:  S De Bruyne; N Van Damme; P Smeets; L Ferdinande; W Ceelen; J Mertens; C Van de Wiele; R Troisi; L Libbrecht; S Laurent; K Geboes; M Peeters
Journal:  Br J Cancer       Date:  2012-05-17       Impact factor: 7.640

7.  [Correlation of aquaporin 3 expression with the clinicopathologic characteristics of non-small cell lung cancer].

Authors:  Bailing Li; Lei Jin; Keng Zhong; Dahai Du
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-07

8.  E-cadherin and NEDD9 expression in primary colorectal cancer, metastatic lymph nodes and liver metastases.

Authors:  Petra Jurčić; Petra Radulović; Melita Perić Balja; Milan Milošević; Božo Krušlin
Journal:  Oncol Lett       Date:  2019-01-10       Impact factor: 2.967

9.  Prognostic Significance of CDH1, FN1 and VIM for Early Recurrence in Patients with Colorectal Liver Metastasis After Liver Resection.

Authors:  Aleksandar Bogdanovic; Jovana Despotovic; Danijel Galun; Nemanja Bidzic; Aleksandra Nikolic; Jovana Rosic; Zoran Krivokapic
Journal:  Cancer Manag Res       Date:  2021-01-11       Impact factor: 3.989

Review 10.  The engagement of selectins and their ligands in colorectal cancer liver metastases.

Authors:  Konstantinos A Paschos; David Canovas; Nigel C Bird
Journal:  J Cell Mol Med       Date:  2010-01       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.